An optimization of hematopoietic stem and progenitor cell isolation for scientific and clinical purposes by the application of a new parameter determining the hematopoietic graft efficacy.

Abstract

The transplantation of hematopoietic stem and progenitor cells (HSPC) is an established lifesaving therapy. Bone marrow (BM), harvested from heparinized cadaveric organ donors, peripheral blood (PB) and cord blood (CB), are important sources of hematopoietic stem cells. HSPCs, which are used for transplantation purposes, are routinely evaluated in terms of… (More)
DOI: 10.2478/v10042-008-0045-0

Topics

5 Figures and Tables

Cite this paper

@article{Baumert2008AnOO, title={An optimization of hematopoietic stem and progenitor cell isolation for scientific and clinical purposes by the application of a new parameter determining the hematopoietic graft efficacy.}, author={Brigitta G. Baumert and Katarzyna Grymuła and Dariusz Pietruszka and Michał Kotowski and M Mielczarek and Viotetta Dziedziejko and Marta Hałasa and Bogusław Czerny and Maureen D Walczak and Boguslaw Machaliński}, journal={Folia histochemica et cytobiologica}, year={2008}, volume={46 3}, pages={299-305} }